American Oriental Bioengineering (AOB) has a market cap $100 million.
American Oriental Bioengineering, Inc. engages in the development and production of bioengineer products and traditional Chinese medicinal products. The company’s product line includes Health Food, Chinese Medical, and Soybean Protein Peptide products. Health Food product series include compound bio-functional beverage, a nutritional beverage; iodine bio-functional beverage, a compound bio-functional beverage with Iodine additives; and vitamate oral liquid, which is designed to strengthen the immue system. Chinese Medical products series include cease enuresis soft gel that helps alleviate bed-wetting and urination disorder; root of red-rooted salvia tablet that improves blood circulation to remove blood stasis; and double ginseng yishen grain, which is useful for those suffering from neurosis. Soybean protein peptide products include soybean protein peptide powder and soybean protein peptide coffee nutritious health drinks; and soybean protein peptide tablets, which maintains or improves protein nutrient condition of the human body. It offers its products through distributors, sales outlets, and hospital and clinics. The company markets its products in China, the United States, Europe, and Brazil. The company was founded as Champion Ventures, Inc. in 1970 and changed its name to Internet Golf Association, Inc. in 1999 as a result of its merger with Internet Golf Association, Inc. Further, the company changed its name to American Oriental Bioengineering, Inc. as per the terms of an agreement to acquire Harbin Three Bioengineering Limited. American Oriental Bioengineering is headquartered in Harbin, China.
******
See #849 for fundamentals.
|
